Newsletter March 2020 No.196
Top News
"Press Conference by the Chairman of the JPMA" Held
On January 27, 2020, the “JPMA Chairman’s Press Conference” was held at the Nomura Conference Plaza Nihonbashi (Chuo Ward, Tokyo).Jōji Nakayama, Chairman of the JPMA, provided an explanation on “Progress and Future Directions of the JPMA’s Initiatives.” Thirty-eight members of the press attended the press conference, and a lively question-and-answer session took place on the day of the event.
Topics
- Drug Resistance (AMR) Seminar" Held
History and Current Status of Countermeasures against Infectious Diseases: Learning from Semmelweis - The 4th Japan-India Symposium on Regulation of Medical Products
Mature Discussions on Japan-India (Japan-India) Regulation of Medical Products and Further Development of International Cooperation Scheme - Project for Promotion of Appropriate Use of Medicines Using Medication Support Tools via Clinical Pharmacists in Vietnam
- The 7th Taiwan-Japan Pharmaceutical Exchange Conference" will be held
- CMC Strategy Forum Japan 1969" was held.
- Workshop on "What Adverse Reaction Case Evaluation Services Should Be
- JPMA Press Tour" was held.
Visit to the Japan Agency for Marine-Earth Science and Technology (JAMSTEC), which promotes the development of deep-sea bio-resources through an open innovation system by providing resources such as deep-sea sediments, deep-sea microbial strains, and genetic information to private companies and other external organizations in Japan.
Connecting with Citizens and Patients
Policy Research Institute
Japan's Presence in the Pharmaceutical Market
Analysis of Overseas Sales Share of Japanese Companies
From JPMA
From the “Press Conference by the President of the JPMA”
